BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20637314)

  • 1. An introduction to a novel population genetic approach for HIV characterization.
    Perez-Sweeney B; DeSalle R; Ho JL
    Infect Genet Evol; 2010 Dec; 10(8):1155-64. PubMed ID: 20637314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates.
    Riley JP; Pestano GA; Harewood K; Alfred LJ; Guyden J; Boto WM
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S83-91. PubMed ID: 8574151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
    Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
    AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 subtypes among Malaysian intravenous drug users.
    Saraswathy TS; Ng KP; Sinniah M
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):283-6. PubMed ID: 11127327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sequence variation in the env V3-V4 region of HIV type 1 predominant subtype B and C strains circulating in China].
    Liang H; Wei M; Chen Z; Xing H; Zhao QB; Feng Y; Guan Q; Shi LY; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):153-8. PubMed ID: 12869999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regions.
    Joos B; Fischer M; Schweizer A; Kuster H; Böni J; Wong JK; Weber R; Trkola A; Günthard HF
    J Infect Dis; 2007 Jul; 196(2):313-20. PubMed ID: 17570120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and phylogenetic characterization of HIV variants in Italian primary HIV infections (PHI): identification of non-B subtype variants.
    Buonaguro L; Tagliamonte M; Tornesello ML; Ciuffreda D; Capiluppi B; Lopalco L; Lazzarin A; Tambussi G; Buonaguro FM
    J Biol Regul Homeost Agents; 2002; 16(1):44-8. PubMed ID: 12003173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV evolution: CTL escape mutation and reversion after transmission.
    Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJ
    Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.
    Borrego P; Marcelino JM; Rocha C; Doroana M; Antunes F; Maltez F; Gomes P; Novo C; Barroso H; Taveira N
    Retrovirology; 2008 Sep; 5():78. PubMed ID: 18778482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loop.
    Leal E; Silva WP; Sucupira MC; Janini LM; Diaz RS
    Virology; 2008 Nov; 381(2):222-9. PubMed ID: 18814897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the evolutionary pressure on the env gene of the human immunodeficiency virus type 1 CRF01-AE strains circulating in China].
    Liang H; Xing H; Wei M; Chen Z; Guan Q; Huang HL; Quan Y; Chen JP; Hong KX; Shi LY; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):966-70. PubMed ID: 14687493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemic origin and molecular properties of B': a founder strain of the HIV-1 transmission in Asia.
    Deng X; Liu H; Shao Y; Rayner S; Yang R
    AIDS; 2008 Sep; 22(14):1851-8. PubMed ID: 18753865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.
    Menzo S; Sampaolesi R; Vicenzi E; Santagostino E; Liuzzi G; Chirianni A; Piazza M; Cohen OJ; Bagnarelli P; Clementi M
    AIDS; 1998 Jun; 12(9):985-97. PubMed ID: 9662194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for negative selective pressure in HIV-2 evolution in vivo.
    Barroso H; Taveira N
    Infect Genet Evol; 2005 Apr; 5(3):239-46. PubMed ID: 15737915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the variation of 32 HIV-1 V3 loop from infected Chinese blood/plasma donors].
    Dai L; Lu JF; Huang XJ; Shi Y; Chen DX; Wu H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):27-9. PubMed ID: 18414693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution of recombinant human immunodeficiency virus type-1 CRF01_AE strains in China and its sequence variations in the env V3-C3 region].
    Xing H; Liang H; Wan ZY; Chen X; Wei M; Ma PF; Guan Q; Quan Y; Hong KX; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):300-4. PubMed ID: 15498240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design?
    de Oliveira T; Salemi M; Gordon M; Vandamme AM; van Rensburg EJ; Engelbrecht S; Coovadia HM; Cassol S
    Genetics; 2004 Jul; 167(3):1047-58. PubMed ID: 15280222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption.
    Silva WP; Santos DE; Leal E; Brunstein A; Sucupira MC; Sabino EC; Diaz RS
    Virology; 2006 Oct; 354(1):35-47. PubMed ID: 16872654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy.
    Frost SD; Günthard HF; Wong JK; Havlir D; Richman DD; Leigh Brown AJ
    Virology; 2001 Jun; 284(2):250-8. PubMed ID: 11384224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.